CLINICAL_TRIALS
trial_result
· 2020-08-28
Clinical Trial Update: Study of Ataluren in ≥2 to <5 Year-Old Male Participants With Duchenne Muscular Dystrophy [Phase 2]
Summary
Phase 2 trial of ataluren in young boys with Duchenne muscular dystrophy completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PTC Therapeutics | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: COMPLETED | Results posted: 2020-08-28